Scholarly Open Access Journals In Pharmacovigilance

The World health organization (WHO) defines pharmacovigilance as “the science and activities relating to the detection, assessment, understanding and prevention of adverse affects or any other possible drug-related problems.” According to US Food and Drug Administration, a serious adverse reaction is one in which the patient outcome is death, life threatening (real risk of dying), hospitalization (initial or prolonged), disability (significant, persistent or permanent), congenital anomaly, or required intervention to prevent permanent impairment or damage. Since Adverse drug reactions (ADR) are common causes of morbidity and mortality in different healthcare settings, it is then very challenging that the Pharmacists are more likely to detect ADRs than other healthcare professionals.

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on April, 2024